Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

August 29, 2019 04:30 ET | Source: Chr. Hansen Holding A/S Chr. Hansen Holding A/S